Non-erodible systems

An alternative system, manufactured as a wafer-like insoluble implant, has been developed (Ocusert). The system is preprogrammed to release pilocarpine at a constant rate of 20 or 40 / g/hr for a week to treat chronic glaucoma however, release from inserts may be incomplete and approximately 20% of all patients treated with the Ocusert lose the device without being aware of the loss. The device also presents problems including foreign-body sensation, expulsion from the eye, and difficulty in handling and insertion. An alternative to the advanced non-erodible systems is an erodible insert for placement in the cul-de-sac. 

The enhanced release was also observed in non-erodible systems exposed to ultrasound where the release is diffusion dependent. This was tested on EVAc copolymers loaded with BSA or insulin. The released insulin was also evaluated by HPLC. No significant difference was detected between insulin samples exposed to ultrasound and unexposed samples, suggesting that the ultrasound is not degrading the releasing molecules. 

Experiments were also performed to evaluate whether the extent of enhancement could be regulated externally. By varying the ultrasound intensity, the degree of enhancement for both polymer degradation and drug release for the bioerodible and non-erodible systems could be altered 10-fold (42). 

The controlled release of macromolecules from non-erodible, hydrophobic polymeric matrices is modelled as a discrete diffusion process with the release of solute occuring through distinct pores in the polymer which are formed as solid particles of molecule dissolve. In order to formulate predictive models of the release behavior of these devices, quantitative information on the microgeometry of the system is required. We present a computer-based system for obtaining estimates of the system porosity, isotropy, particle shape, and particle size distribution from observations on two-dimensional sections from the polymer matrix. 

Of course, insulin release is not the unique target in the dehvery field. Indeed, for example, Ishihara [47] matches the problem of urea release using a non-erodible membrane. The system is constituted by a pH-sensitive membrane (copolymerization of 4-carboxyacrylanilide and methacrylate) sandwiched among a membrane containing urease immobilized in free radically cross-linked A, A -methylenebisacrylamide. System permeability with respect to a model dmg ((1,4-bis-(2-hydroxyethoxy)benzene) varies with urea concentration in the external environment. 

Polymeric materials for continuous long-term release of entrapped substances (excipients) have been utilized extensively in the last two decades in drug delivery systems. These polymers can be classified into two major groups as shown in Table I. The non-erodible carriers, such as polyacrylamide, polyvinyl alcohol and poly(2-hydroxy methacrylate) have been used widely in sensor preparation mainly as supports for physical or chemical immobilization of fluorescent molecules or enzymes. As discussed above, EVA has been shown to be appropriate as a reservoir polymer for sensor development. 

The area of applied bioactive polymeric systems includes such diverse entities as controlled release systems (erodable systems, diffusion controlled systems, mechanical systems and microcapsules), and biologically active polymers, such as natural polymers, synthetic polypeptides, pseudo-enzymes, pseudo-nucleic acids and polymeric drugs. The area can also include immobilized bioactive materials, such as immobilized enzymes, antibodies and other bioactive agents and the area of artificial cells. This Chapter reviews the general field of biologically active synthetic and modified natural macromolecules with an emphasis on their common characteristics, problems and applications. The areas reviewed include both medical and non-medical applications for both controlled release systems and polymers that exhibit direct biological activity. 

In spite of the non-achievement of front movement synchronization, when such systems are needed In pharmaceutical applications constant drug release has been observed at later times, i.e. when the swelling front is no longer active. The systems behave from that moment on as classical erodible systems with synchronization of the diffusing and eroding fronts (Figure 8). 

Even though polymer-coated metallic DES have revolutionized the treatment of obstructive coronary diseases, they do not provide an optimal solution [161]. FDA reports and autopsy findings suggest that metallic DES may be a cause of systemic and intrastent hypersensitivity reactions that, in some cases, have been associated with late thrombosis and death [162]. Other reports have further suggested that the most likely cause of the hypersensitivity reaction is the non-erodable polymer coating of the DES [145, 146, 163]. Additionally, in-stent restenosis may be associated with allergic reactions to the nickel (stent component) and molybdenum (stent impurity) in metallic stents [146, 164]. 

An alternative theory associates electron transfer with transfer of a state of aromaticity from molecule to molecule within the stack (77AG(E)519). Efficient charge transport was identified with conversion of a neutral, antiaromatic system to a charged, aromatic radical by electron transfer. This interpretation has been eroded by the synthesis of conductors from aromatic systems such as perylene hexafluoroarsenate (81MI11301) or polypyrrole tetrafluoroborate (80CC397, 81MI11300) where an electron is transferred from a neutral, aromatic molecule to a non-aromatic charged radical. 

In the early 1970s, the ALZA Corporation began its search for polymers suitable for erodible drug delivery systems. The ideal polymer was identified as one undergoing surface erosion in vivo and degrading to non-toxic, low molecular weight products at a rate that could be manipulated over a broad time span. To meet these criteria, a novel family of hydrolyzable polymers was developed, the poly(orthoesters), POEs [285]. The general structure is schematically shown in... 

Hard coal product has increased from less than 1 billion ton to almost 5 million ton from 1900 to 2005 [1]. Due to coal mining, coal industry, atmospheric transport, runoff, and flooding etc, unbumt coal and coal-derived partieles ean be wild spread in the aquatic system, and consequently settled in sediments. For example, imbumt eoal particles can be released by open pit mining coal stored at industrial sites for the produetion of coke, gas or steam, is subjected to erosion moreover, eoal naturally eroded into aquatic systems for sedimentary rock outcroppings containing coal seams. Oeeurrence of coal in sediments was reported from harbors such as Hamilton Harbour [2] and Roberts Bank coal terminal, in Canada [3]. Coal particles present in sediments made up 10.5 to 11.9 % dry weight of the soil mass in the vicinity of coal-loading terminals and was reported as non-hydrolysable solids. 

---